review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Robert Kiss | |
Florence Lefranc | |||
Vincenzo Facchini | |||
P433 | issue | 12 | |
P921 | main subject | apoptotic process | Q14599311 |
P304 | page(s) | 1395-1403 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | Oncologist | Q2122327 |
P1476 | title | Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas | |
P478 | volume | 12 |
Q36001206 | 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. |
Q30501296 | A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells |
Q47549547 | A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma |
Q91660900 | A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy |
Q33861997 | A novel sphingosine kinase inhibitor induces autophagy in tumor cells |
Q64062204 | An autophagy-related long non-coding RNA signature for glioma |
Q39205434 | Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier |
Q47139059 | Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells |
Q35170361 | Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme |
Q39167592 | Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment |
Q43164842 | Apoptotic effects of Physalis minima L. chloroform extract in human breast carcinoma T-47D cells mediated by c-myc-, p53-, and caspase-3-dependent pathways |
Q36214996 | Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. |
Q47104641 | Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines |
Q34764083 | Autophagy in lung cancer |
Q37533134 | Autophagy in tumour suppression and promotion |
Q34132803 | Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines |
Q28478548 | Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells |
Q39883954 | Autophagy pathways in glioblastoma |
Q37472903 | Autophagy: from basic science to clinical application |
Q36148612 | BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide |
Q27026080 | Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles |
Q34154107 | Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells. |
Q39731113 | Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma? |
Q34979866 | Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells |
Q37407166 | Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells |
Q28483643 | Characterization of isoenzyme-selective inhibitors of human sphingosine kinases |
Q90361899 | Chemical Characteristics and Anticancer Activity of Essential Oil from Arnica Montana L. Rhizomes and Roots |
Q37821750 | Chemical modulators of autophagy as biological probes and potential therapeutics |
Q36248399 | Chemistry of the nudibranch Aldisa andersoni: structure and biological activity of phorbazole metabolites. |
Q39712685 | Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent |
Q35133418 | Cilengitide induces autophagy-mediated cell death in glioma cells |
Q37820312 | Clinical and molecular insights into tuberous sclerosis complex renal disease. |
Q48132579 | Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance. |
Q38791893 | Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. |
Q34662536 | Combined efficacy of cediranib and quinacrine in glioma is enhanced by hypoxia and causally linked to autophagic vacuole accumulation |
Q36982114 | Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model |
Q39555301 | Considering temozolomide as a novel potential treatment for esophageal cancer |
Q33939106 | DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. |
Q91260488 | Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging |
Q28487918 | Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells |
Q48240259 | EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest. |
Q34110809 | Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma |
Q39349204 | Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death |
Q30504024 | Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy |
Q36586507 | Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. |
Q38416699 | Evaluation of chemopreventive potentials of ethanolic extract of Ruta graveolens against A375 skin melanoma cells in vitro and induced skin cancer in mice in vivo |
Q82884131 | Ewing's sarcoma |
Q37165859 | Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression |
Q34268364 | Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion. |
Q35228388 | Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior |
Q33588438 | Galectins and gliomas |
Q37724209 | Glioblastoma therapy: going beyond Hercules Columns. |
Q52645882 | Glioblastoma-derived cells in vitro unveil the spectrum of drug resistance capability - comparative study of tumour chemosensitivity in different culture systems. |
Q39413826 | Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. |
Q39042761 | Graveoline isolated from ethanolic extract of Ruta graveolens triggers apoptosis and autophagy in skin melanoma cells: a novel apoptosis-independent autophagic signaling pathway. |
Q47664663 | High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux |
Q33753801 | Histone deacetylase 10 structure and molecular function as a polyamine deacetylase |
Q28301209 | Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells |
Q84273446 | Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues |
Q29614498 | Induction of autophagy by spermidine promotes longevity |
Q35374492 | Innovative Therapies against Human Glioblastoma Multiforme |
Q34197351 | Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas? |
Q39671678 | Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells |
Q30500762 | JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation |
Q39538477 | Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. |
Q21284430 | Lectin of Concanavalin A as an anti-hepatoma therapeutic agent |
Q34105361 | Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression |
Q39447204 | MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis |
Q38833604 | Mechanisms of autophagy and apoptosis: Recent developments in breast cancer cells |
Q26738528 | Mechanisms of drug resistance in colon cancer and its therapeutic strategies |
Q39297355 | Metabolic Reprogramming in Glioma. |
Q39239705 | Metformin treatment reduces temozolomide resistance of glioblastoma cells |
Q37731350 | Methods for detecting autophagy and determining autophagy-induced cell death. |
Q39491915 | Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells. |
Q37940741 | Modulating autophagy: a strategy for cancer therapy |
Q28535039 | NETRIN-4 protects glioblastoma cells FROM temozolomide induced senescence |
Q37993775 | Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers |
Q55463679 | Necroptosis: A novel therapeutic target for glioblastoma |
Q42567117 | Novel Insights into the Interplay between Apoptosis and Autophagy |
Q60907786 | Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender |
Q37053235 | Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis. |
Q35534091 | PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway |
Q37459257 | Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells |
Q37444920 | Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. |
Q37466253 | Programmed cell death pathways and current antitumor targets |
Q37312695 | Quinacrine synergistically enhances the antivascular and antitumor efficacy of cediranib in intracranial mouse glioma |
Q42244908 | Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells |
Q34632817 | Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells |
Q36092988 | Schidandrin B kills tumor cells by initiating apoptosis in glioma SHG-44 cells |
Q34805282 | Shikonin kills glioma cells through necroptosis mediated by RIP-1 |
Q36959477 | TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells |
Q39926475 | TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia |
Q34974464 | TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling |
Q49238970 | Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo |
Q33758340 | Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment |
Q54559220 | Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. |
Q39003499 | Tetrandrine and caffeine modulated cell cycle and increased glioma cell death via caspase-dependent and caspase-independent apoptosis pathways. |
Q39700227 | The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma |
Q24297013 | The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion |
Q44997969 | The combination of antitumor drugs, exemestane and erlotinib, induced resistance mechanism in H358 and A549 non-small cell lung cancer (NSCLC) cell lines. |
Q38255481 | The future of glioblastoma therapy: synergism of standard of care and immunotherapy |
Q35142283 | The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation |
Q38780472 | The potential roles of dopamine in malignant glioma |
Q35893442 | The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment |
Q36485266 | The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas |
Q34518826 | The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction |
Q28273012 | Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents |
Q37295514 | Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release |
Q47231432 | mTOR-Dependent Cell Proliferation in the Brain. |
Q39136340 | microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells |
Search more.